Optimization of the lyophilization process for long-term stability of solid-lipid nanoparticles

Area of Science:

• Pharmaceutical Nanotechnology
• Drug Delivery Systems
• Materials Science

Background:

• Solid-lipid nanoparticles (SLNs) are promising drug delivery vehicles.
• Lyophilization is a common method for stabilizing nanoparticles.
• Optimizing lyophilization is crucial for maintaining SLN integrity and drug efficacy.

Purpose of the Study:

• To optimize a lyophilization protocol for dexamethasone palmitate (Dex-P)-loaded SLNs.
• To evaluate the long-term stability of lyophilized SLNs versus aqueous suspensions.
• To determine optimal storage conditions for lyophilized SLNs.

Main Methods:

• Investigated the impact of lyophilization parameters on SLN redispersibility.
• Assessed particle size, polydispersity index, and drug loading.
• Conducted a three-month stability study under different storage conditions (4°C and 25°C/60% RH).

Main Results:

• Sucrose was identified as the most effective lyoprotectant for SLN redispersibility.
• Optimized lyophilization parameters included higher freezing temperatures, slower freezing rates, and longer secondary drying times.
• Lyophilized SLNs stored at 4°C maintained particle size and showed minimal drug loss (<20%) over three months.
• Aqueous SLN suspensions showed significant particle growth and drug loss at 25°C/60% RH.

Conclusions:

• A robust lyophilization protocol was established for Dex-P-loaded SLNs, ensuring minimal changes in physicochemical properties upon reconstitution.
• Lyophilized SLNs stored at 4°C demonstrated excellent long-term stability, preserving particle size and drug retention.
• Lyophilization offers a viable strategy for enhancing the shelf-life of SLN formulations.